NEW YORK (GenomeWeb News) – Response Biomedical today reported that its first-quarter revenues rose 131 percent, while its net loss fell around 50 percent.

The Vancouver, BC-based genetic test maker brought in revenues of C$2.7 million (US$2.3 million) for the three-month period ended March 31, compared to revenues of C$1.2 million. The firm said the boost was primarily due to a "significant contribution by Roche Diagnostics' launch of RAMP Cardiac products in the US."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.